- Summary
- Actions
- Committee Votes
- Floor Votes
- Memo
- Text
- LFIN
- Chamber Video/Transcript
S02677 Summary:
| BILL NO | S02677A |
|   | |
| SAME AS | SAME AS A00463-A |
|   | |
| SPONSOR | BRESLIN |
|   | |
| COSPNSR | HOYLMAN-SIGAL, SKOUFIS |
|   | |
| MLTSPNSR | |
|   | |
| Amd 4902 & 4903, Ins L; amd 4902 & 4903, Pub Health L | |
|   | |
| Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination. | |